carilex medical limited Company Information
Company Number
10472576
Next Accounts
Sep 2025
Industry
Other business support service activities n.e.c.
Directors
Shareholders
carilex medical inc
Group Structure
View All
Contact
Registered Address
unit b3 chaucer business park, dittons road, polegate, east sussex, BN26 6QH
Website
carilexmedical.comcarilex medical limited Estimated Valuation
Pomanda estimates the enterprise value of CARILEX MEDICAL LIMITED at £242k based on a Turnover of £614k and 0.39x industry multiple (adjusted for size and gross margin).
carilex medical limited Estimated Valuation
Pomanda estimates the enterprise value of CARILEX MEDICAL LIMITED at £142.3k based on an EBITDA of £50.8k and a 2.8x industry multiple (adjusted for size and gross margin).
carilex medical limited Estimated Valuation
Pomanda estimates the enterprise value of CARILEX MEDICAL LIMITED at £2.1m based on Net Assets of £872.9k and 2.37x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Carilex Medical Limited Overview
Carilex Medical Limited is a live company located in polegate, BN26 6QH with a Companies House number of 10472576. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in November 2016, it's largest shareholder is carilex medical inc with a 100% stake. Carilex Medical Limited is a young, small sized company, Pomanda has estimated its turnover at £614k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Carilex Medical Limited Health Check
Pomanda's financial health check has awarded Carilex Medical Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 6 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
6 Weak
Size
annual sales of £614k, make it smaller than the average company (£4.8m)
- Carilex Medical Limited
£4.8m - Industry AVG
Growth
3 year (CAGR) sales growth of -34%, show it is growing at a slower rate (6.7%)
- Carilex Medical Limited
6.7% - Industry AVG
Production
with a gross margin of 16.9%, this company has a higher cost of product (38.2%)
- Carilex Medical Limited
38.2% - Industry AVG
Profitability
an operating margin of 8.3% make it more profitable than the average company (5.7%)
- Carilex Medical Limited
5.7% - Industry AVG
Employees
with 2 employees, this is below the industry average (27)
2 - Carilex Medical Limited
27 - Industry AVG
Pay Structure
on an average salary of £54k, the company has an equivalent pay structure (£54k)
- Carilex Medical Limited
£54k - Industry AVG
Efficiency
resulting in sales per employee of £307k, this is more efficient (£171.5k)
- Carilex Medical Limited
£171.5k - Industry AVG
Debtor Days
it gets paid by customers after 76 days, this is later than average (41 days)
- Carilex Medical Limited
41 days - Industry AVG
Creditor Days
its suppliers are paid after 196 days, this is slower than average (32 days)
- Carilex Medical Limited
32 days - Industry AVG
Stock Days
it holds stock equivalent to 494 days, this is more than average (33 days)
- Carilex Medical Limited
33 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 62 weeks, this is more cash available to meet short term requirements (22 weeks)
62 weeks - Carilex Medical Limited
22 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 23.9%, this is a lower level of debt than the average (62.4%)
23.9% - Carilex Medical Limited
62.4% - Industry AVG
CARILEX MEDICAL LIMITED financials
Carilex Medical Limited's latest turnover from December 2023 is estimated at £614 thousand and the company has net assets of £872.9 thousand. According to their latest financial statements, Carilex Medical Limited has 2 employees and maintains cash reserves of £327.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
---|---|---|---|---|---|---|---|
Turnover | |||||||
Other Income Or Grants | |||||||
Cost Of Sales | |||||||
Gross Profit | |||||||
Admin Expenses | |||||||
Operating Profit | |||||||
Interest Payable | |||||||
Interest Receivable | |||||||
Pre-Tax Profit | |||||||
Tax | |||||||
Profit After Tax | |||||||
Dividends Paid | |||||||
Retained Profit | |||||||
Employee Costs | |||||||
Number Of Employees | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
---|---|---|---|---|---|---|---|
Tangible Assets | 539 | 634 | 0 | 108 | 3,749 | 10,768 | 20,581 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 539 | 634 | 0 | 108 | 3,749 | 10,768 | 20,581 |
Stock & work in progress | 690,923 | 1,016,188 | 1,040,830 | 1,504,073 | 0 | 1,232,641 | 786,191 |
Trade Debtors | 127,996 | 181,486 | 80,515 | 254,399 | 2,296,951 | 389,457 | 965,316 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 5,048 | 42,322 | 12,888 |
Cash | 327,936 | 250,481 | 332,575 | 221,421 | 0 | 738,314 | 438,952 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,146,855 | 1,448,155 | 1,453,920 | 1,979,893 | 2,301,999 | 2,402,734 | 2,203,347 |
total assets | 1,147,394 | 1,448,789 | 1,453,920 | 1,980,001 | 2,305,748 | 2,413,502 | 2,223,928 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 274,400 | 1,025,161 | 1,105,650 | 1,673,511 | 2,000,158 | 2,106,617 | 1,878,820 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 7,251 | 50,616 |
total current liabilities | 274,400 | 1,025,161 | 1,105,650 | 1,673,511 | 2,000,158 | 2,113,868 | 1,929,436 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 4,140 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 102 | 120 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 102 | 120 | 0 | 0 | 4,140 | 0 | 0 |
total liabilities | 274,502 | 1,025,281 | 1,105,650 | 1,673,511 | 2,004,298 | 2,113,868 | 1,929,436 |
net assets | 872,892 | 423,508 | 348,270 | 306,490 | 301,450 | 299,634 | 294,492 |
total shareholders funds | 872,892 | 423,508 | 348,270 | 306,490 | 301,450 | 299,634 | 294,492 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
---|---|---|---|---|---|---|---|
Operating Activities | |||||||
Operating Profit | |||||||
Depreciation | 95 | 61 | 108 | 0 | 6,603 | 3,513 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | |
Tax | |||||||
Stock | -325,265 | -24,642 | -463,243 | 1,504,073 | -1,232,641 | 446,450 | 786,191 |
Debtors | -53,490 | 100,971 | -173,884 | -2,047,600 | 1,870,220 | -546,425 | 978,204 |
Creditors | -750,761 | -80,489 | -567,861 | -326,647 | -106,459 | 227,797 | 1,878,820 |
Accruals and Deferred Income | 0 | 0 | 0 | -4,140 | -3,111 | -43,365 | 50,616 |
Deferred Taxes & Provisions | -18 | 120 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||
Investing Activities | |||||||
capital expenditure | |||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||
Financing Activities | |||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||
interest | |||||||
cash flow from financing | |||||||
cash and cash equivalents | |||||||
cash | 77,455 | -82,094 | 111,154 | 221,421 | -738,314 | 299,362 | 438,952 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 77,455 | -82,094 | 111,154 | 221,421 | -738,314 | 299,362 | 438,952 |
carilex medical limited Credit Report and Business Information
Carilex Medical Limited Competitor Analysis
Perform a competitor analysis for carilex medical limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other small companies, companies in BN26 area or any other competitors across 12 key performance metrics.
carilex medical limited Ownership
CARILEX MEDICAL LIMITED group structure
Carilex Medical Limited has no subsidiary companies.
Ultimate parent company
CARILEX MEDICAL INC
#0089363
1 parent
CARILEX MEDICAL LIMITED
10472576
carilex medical limited directors
Carilex Medical Limited currently has 1 director, Mr Wei-Hsun Cheng serving since Mar 2021.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Wei-Hsun Cheng | England | 45 years | Mar 2021 | - | Director |
P&L
December 2023turnover
614k
-53%
operating profit
50.7k
0%
gross margin
17%
-1.39%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
872.9k
+1.06%
total assets
1.1m
-0.21%
cash
327.9k
+0.31%
net assets
Total assets minus all liabilities
carilex medical limited company details
company number
10472576
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
November 2016
age
9
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
unit b3 chaucer business park, dittons road, polegate, east sussex, BN26 6QH
Bank
-
Legal Advisor
-
carilex medical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to carilex medical limited.
carilex medical limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CARILEX MEDICAL LIMITED. This can take several minutes, an email will notify you when this has completed.
carilex medical limited Companies House Filings - See Documents
date | description | view/download |
---|